CD46 and breast carcinoma: Recent researches about Hepatitis B X-interacting protein (HBXIP) function on the breast cancer cells has been shown that CD55, CD59, and CD46 are up-regulated through p-ERK1/2/NF-jB signaling to protect breast cancer from complement-dependent cytotoxicity [215].